Results for tag: "Epigenetic Diagnostics"

The Epigenetic Diagnostics market is a subset of the larger Genomics market. It focuses on the study of epigenetic changes, which are modifications to the genome that do not involve changes to the underlying DNA sequence. These changes can be used to diagnose and treat a variety of diseases, including cancer, neurological disorders, and autoimmune diseases. Epigenetic diagnostics can also be used to identify individuals at risk for certain diseases, allowing for earlier intervention and better outcomes. Epigenetic diagnostics is a rapidly growing field, with a wide range of applications. Companies in the market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and Oxford Nanopore Technologies. Show Less Read more